The British success story continues apace as the biggest
names in food, cosmetics, personal care & agritech globally
look to confirm the positive biological impact of next-generation
products, and play their part in solving real-world challenges
capitalising on the worldwide microbiome megatrend
CAMBRIDGE, England,
May 4, 2021 /PRNewswire/
-- Eagle Genomics, a British pioneer in applying network
science to biology, has announced the opening of a formal new
operation in India – within the
innovation hub of Laxmi Cyber City in Hyderabad - as the bio revolution continues to
transform the global economy.
Eagle Genomics has been hitting the headlines over the last
year, with its ground-breaking approach to networking microbiome
science - with its e[datascientist]™ knowledge
discovery platform - to help address the world's grand
challenges including a secure and sustainable future for our food,
water, soil, health and the planet.
The on-the-ground expansion into Hyderabad, the capital of southern
India's Telangana state and a
major centre for the technology and biotechnology industries
(India's Genome Valley is close),
marks the latest milestone in Eagle Genomics' customer-driven
expansion. The successful and fast-growing British scale-up
company, whose revenues have soared by 300 per cent over the last
year, sees India as a critical
base as part of its continued international expansion. The company,
which will soon launch a major new funding round, already has a hub
in New York's Genome Center and
further bases in Paris and
Berlin.
Eagle Genomics already had a team of around 20 engineers working
in Hyderabad, India, but the team
will now be very significantly expanded with its own brand new
office space in the prestigious Laxmi Cyber City innovation
hub.
UK Prime Minister Boris Johnson
said, "I'm delighted that Eagle Genomics is expanding into
India to make the most of the
opportunities for UK businesses in one of the world's biggest
economies. Our exporters are brilliant ambassadors for Britain, and I hope today's announcement is
just the start of what you can do for India and the UK."
"The buildout of both the engineering and science teams in
Hyderabad has already had a
significant impact on Eagle Genomics' growth," commented
Anthony Finbow, Eagle Genomics' CEO.
"We have been able to hire highly skilled, talented engineers in
quantities and at a speed that we would not have been able to
achieve had we sought to hire in the UK alone. This increased
capacity, which will also lead to more hires in the UK to serve the
vast Indian opportunity, is already positively impacting the
cadence of our platform development, which opens up additional
customer verticals and directly leads to growth in terms of
customers won and the access to our most proximate addressable
markets."
Eagle Genomics is also forging strategic relationships with some
of the leading scientific establishments in India focused on the microbiome, just as it
has done in other markets most notably the UK, where the company
has helped shape the Microbiome Strategic Roadmap. Eagle Genomics
plans to be at the forefront of the Bio Revolution and sees
microbiome science as the key to unlocking its potential.
Deepak Bagla, CEO of Invest
India, added, "We are delighted to support Eagle Genomics on its
India expansion plans. Eagle
Genomics has made the right decision: to expand cutting-edge
emerging technology innovation by partnering with India. Collaboration between UK and Indian
organisations – with our ability to build world-class innovation
and businesses together – is a recipe for truly global
competitiveness."
India's interest in the
microbiome is rising quickly. To date, organisations including
ICAR: the Indian Council of Agricultural Research; ICRISAT: The
International Crops Research Institute for the Semi-Arid Tropics;
ICMR: The Indian Council of Medical Research (ICMR); Bangalore Life
Science Cluster (BLiSC); and DBT: The Department of Biotechnology
are increasing their research into the role of the microbiome on
crop growth, population health, environmental sustainability, and
more.
Eagle Genomics, which turned its focus to the microbiome in
2018, will drive further expansion with a new round of funding
planned for the second half of this year. Current Investors include
Environmental Technologies Fund (ETF) and a consortium of investors
from across science, AI and analytics fields led by Granpool
Innovative Investments. Global revenues have grown by 300 per cent
year on year over the most recent 12-month period.
Eagle Genomics' impressive track record is down to the company's
unique microbiome network science, which it is putting in the hands
of commercial R&D teams with its e[datascientist]
platform. Its global customers include the likes of Unilever and
Cargill, brands which have understood the substantial role of
microbes in maintaining health and wellbeing and promoting renewal
of the natural environment.
About Eagle Genomics
Eagle Genomics, headquartered in Cambridge, UK, innovates at the intersection
of biology, data sciences and bioinformatics. The company
specialises in delivering powerful enterprise platform solutions
for innovation in the microbiomics and genomics era. Its
award-winning[1] AI-augmented knowledge discovery platform,
e[datascientist]™, helps companies conduct science
led innovation for next-generation food, personal care, cosmetics
and agritech products. The platform harnesses causal network
science, and advanced machine learning and cognitive services.
Eagle Genomics was founded in 2008 with a focus on human DNA
discovery in biotech and pharma, before relaunching almost a decade
later with a new mission - to apply network science to
microbiome-related discovery. In 2018 it became Microsoft Genomics'
first microbiome partner. Today the fast-growing global business
has operations in the world's major centres for genomics and AI.
These include Cambridge's Wellcome
BioData Innovation Centre and London's Knowledge Quarter in the UK;
Microsoft's AI Factory in Paris;
Potsdam Science Park; JLABS in New
York, and the new facility in Laxmi Cyber City in
Hyderabad, India.
Eagle Genomics works with 5 of the top 10 household and personal
care companies in the world to create and launch new products which
work in harmony with the human and ecological microbiome. Find out
more at www.eaglegenomics.com.
Logo:
https://mma.prnewswire.com/media/1321022/Eagle_Genomics_Logo.jpg
Press contact for Eagle Genomics
Carina Birt, Sarum PR
+44 (0)797-000-6624
carina@sarumpr.com
[1] BioIT World 'Best of Show'; Hello Tomorrow Top 500
Deeptech Startup, Microsoft AI Factory, EIT Food Rising Star, WBCSD
FReSH Gamechanger